Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 961 | 1124 | 966 | 1204 | 1676 |
Fund Return | 5.68% | -3.9% | 12.41% | -1.13% | 3.78% | 5.3% |
Place in category | 565 | 350 | 577 | 411 | 398 | 220 |
% in Category | 85 | 53 | 89 | 76 | 81 | 76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VF CH Valiant Swiss Equities SPI S | 552.75M | 6.30 | -0.43 | 6.03 | ||
LO Institutional Strategies CH Swi | 424.97M | 11.95 | 2.15 | 5.77 | ||
LO Institutional Strategies CH Swis | 424.97M | 4.80 | -1.02 | 5.45 | ||
Avadis VermOgensbildung SICAV Strat | 261.29M | 7.80 | -0.52 | 3.71 | ||
CH0364960218 | 237.37M | 5.94 | -0.08 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.34B | 9.28 | 2.17 | 6.28 | ||
Raiffeisen Futura Swiss Stock A | 2.15B | 7.92 | -0.59 | 6.39 | ||
UBS CH Equity Fund Swiss Income CHF | 2.04B | 2.43 | 3.56 | 5.81 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.04B | 2.59 | 4.20 | 6.41 | ||
Pictet CH Institutional Swiss EquiI | 1.72B | 11.30 | 1.45 | 7.20 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 13.58 | 78.74 | +1.31% | |
Novartis | CH0012005267 | 13.29 | 92.73 | +0.85% | |
Roche Holding Participation | CH0012032048 | 12.86 | 261.60 | -0.57% | |
ABB | CH0012221716 | 5.40 | 50.22 | +1.03% | |
Zurich Insurance Group | CH0011075394 | 5.06 | 526.40 | +1.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review